H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)

Go back to H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)
(NYSE: LCTX) Delayed: 1.02 -0.01 (0.97%)
Previous Close $1.03    52 Week High
Open $1.02    52 Week Low
Day High $1.03    P/E N/A 
Day Low $1.00    EPS
Volume 1,197,740